This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: Academisch Ziekenhuis Leiden (h.o.d.n. Lumc), Other. Active years: 2017-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2017-2020
Title: The Innovations of Petrus Antonius Van Veelen
Introduction
Petrus Antonius Van Veelen is a notable inventor based in Leiden, Netherlands. He has made significant contributions to the field of medical research, particularly in the area of arthritis diagnosis and treatment. With a total of three patents to his name, Van Veelen's work has the potential to impact many lives.
Latest Patents
One of his latest patents focuses on anti-carbamylated protein antibodies and their relevance to arthritis. This patent describes means and methods for determining antibodies against homocitrulline-containing proteins or carbamylated proteins/peptides, known as anti-CarP. These methods are crucial for classifying individuals who are suffering from or at risk of developing arthritis. The significance of antibodies against citrullinated protein antigens (ACPA) in diagnosing and understanding the pathogenesis of arthritis is also highlighted in his work.
Career Highlights
Throughout his career, Van Veelen has worked at Academisch Ziekenhuis Leiden, also known as LUMC. His research has contributed to advancements in understanding autoimmune diseases, particularly arthritis. His innovative approaches have garnered attention in the medical community.
Collaborations
Some of his notable coworkers include Leendert Adrianus Trouw and Reinaldus Everardus Maria Toes. Their collaborative efforts have furthered research in the field and have led to significant findings in arthritis-related studies.
Conclusion
Petrus Antonius Van Veelen's contributions to medical research, particularly in arthritis, demonstrate his commitment to innovation and improving patient outcomes. His patents and collaborations reflect a dedication to advancing scientific knowledge in this important area.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile